PHARMCO II ApS: Financial statements 2017
CVR: 25202899
Source: annual report 2017, Danish Business Authority
01/01/2017 – 31/12/2017
PHARMCO II ApS (CVR 25202899) has filed annual accounts for 2017. In 2017, the company reported a gross profit of DKK -18,126 and a net result of DKK 2,785,070 compared with DKK 2,271,044 the year before. Equity in the 2017 report amounted to DKK 59,493,125. The solvency ratio was 98.7%.
- Gross Profit
- DKK -18,126
- Profit/Loss
- DKK 2,785,070
- Equity
- DKK 59,493,125
- Total Assets
- DKK 60,247,237
Development
| Year | Revenue | Gross Profit | Profit/Loss | Equity | Employees |
|---|---|---|---|---|---|
| 2017 | - | -18 t. | 2.8 mio. | 59.5 mio. | - |
| 2016 | - | -21 t. | 2.3 mio. | 56.7 mio. | - |
| 2015 | - | 17.8 mio. | 3 mio. | - | 37 |
| 2014 | - | -21 t. | 1.8 mio. | 52.8 mio. | 34 |
| 2013 | - | -19 t. | 3.6 mio. | 51.1 mio. | - |
Official annual report
Keep an eye on PHARMCO II ApS
Get notified instantly about new financial statements, ownership changes, management changes and status changes.
Set up monitoringEvents in 2017
PHARMCO II ApS has published its annual report for 2016. Gross profit came to DKK -20,625, and the net result was DKK 2,271,044.
About PHARMCO II ApS
PHARMCO II ApS is a Danish company of the type Anpartsselskab based in Vojens, founded in 2000. The company is registered under the industry Ikke-finansielle holdingselskaber. The management consists of Eli Wallin. The company is owned by Eli Wallin and PharmCo III ApS. According to the 2025 annual report, the company had an average of 66 employees. In 2025, the company reported a gross profit of DKK -56,000 and a net result of DKK 34,432,000 compared with DKK 7,096,622 the year before. Equity in the 2025 report amounted to DKK 107,079,000.